nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP3A4—Thiotepa—urinary bladder cancer	0.0613	0.279	CbGbCtD
Cilostazol—CYP3A5—Etoposide—urinary bladder cancer	0.0427	0.194	CbGbCtD
Cilostazol—CYP1A2—Fluorouracil—urinary bladder cancer	0.038	0.173	CbGbCtD
Cilostazol—CYP1A2—Etoposide—urinary bladder cancer	0.0317	0.145	CbGbCtD
Cilostazol—PDE3A—penis—urinary bladder cancer	0.0308	0.309	CbGeAlD
Cilostazol—CYP2D6—Doxorubicin—urinary bladder cancer	0.0178	0.0812	CbGbCtD
Cilostazol—CYP3A4—Etoposide—urinary bladder cancer	0.0166	0.0757	CbGbCtD
Cilostazol—CYP3A4—Doxorubicin—urinary bladder cancer	0.0113	0.0517	CbGbCtD
Cilostazol—CYP2C19—urine—urinary bladder cancer	0.0111	0.111	CbGeAlD
Cilostazol—CYP1A2—urine—urinary bladder cancer	0.00906	0.091	CbGeAlD
Cilostazol—PDE3A—prostate gland—urinary bladder cancer	0.00735	0.0738	CbGeAlD
Cilostazol—CYP3A4—urine—urinary bladder cancer	0.00656	0.0659	CbGeAlD
Cilostazol—CYP2D6—urine—urinary bladder cancer	0.00646	0.0648	CbGeAlD
Cilostazol—PDE3A—smooth muscle tissue—urinary bladder cancer	0.0052	0.0522	CbGeAlD
Cilostazol—PDE3A—female reproductive system—urinary bladder cancer	0.00401	0.0403	CbGeAlD
Cilostazol—CYP3A5—prostate gland—urinary bladder cancer	0.00314	0.0315	CbGeAlD
Cilostazol—PDE3A—lymph node—urinary bladder cancer	0.00235	0.0236	CbGeAlD
Cilostazol—CYP1A2—renal system—urinary bladder cancer	0.00222	0.0223	CbGeAlD
Cilostazol—CYP3A5—renal system—urinary bladder cancer	0.00214	0.0215	CbGeAlD
Cilostazol—CYP2C19—vagina—urinary bladder cancer	0.00197	0.0197	CbGeAlD
Cilostazol—CYP3A4—renal system—urinary bladder cancer	0.00161	0.0161	CbGeAlD
Cilostazol—CYP2D6—renal system—urinary bladder cancer	0.00158	0.0159	CbGeAlD
Cilostazol—CYP3A5—vagina—urinary bladder cancer	0.00155	0.0156	CbGeAlD
Cilostazol—CYP3A4—female reproductive system—urinary bladder cancer	0.00129	0.0129	CbGeAlD
Cilostazol—CYP2D6—female reproductive system—urinary bladder cancer	0.00127	0.0127	CbGeAlD
Cilostazol—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000415	0.000778	CcSEcCtD
Cilostazol—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000411	0.000769	CcSEcCtD
Cilostazol—Paraesthesia—Etoposide—urinary bladder cancer	0.00041	0.000768	CcSEcCtD
Cilostazol—Haematuria—Methotrexate—urinary bladder cancer	0.000409	0.000766	CcSEcCtD
Cilostazol—Dyspnoea—Etoposide—urinary bladder cancer	0.000407	0.000762	CcSEcCtD
Cilostazol—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000406	0.00076	CcSEcCtD
Cilostazol—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000405	0.000759	CcSEcCtD
Cilostazol—Epistaxis—Methotrexate—urinary bladder cancer	0.000404	0.000757	CcSEcCtD
Cilostazol—Vomiting—Thiotepa—urinary bladder cancer	0.000404	0.000757	CcSEcCtD
Cilostazol—Pneumonia—Epirubicin—urinary bladder cancer	0.000403	0.000756	CcSEcCtD
Cilostazol—Rash—Thiotepa—urinary bladder cancer	0.000401	0.000751	CcSEcCtD
Cilostazol—Bronchitis—Doxorubicin—urinary bladder cancer	0.0004	0.00075	CcSEcCtD
Cilostazol—Dermatitis—Thiotepa—urinary bladder cancer	0.0004	0.00075	CcSEcCtD
Cilostazol—Agranulocytosis—Methotrexate—urinary bladder cancer	0.0004	0.000749	CcSEcCtD
Cilostazol—Headache—Thiotepa—urinary bladder cancer	0.000398	0.000746	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000398	0.000745	CcSEcCtD
Cilostazol—Decreased appetite—Etoposide—urinary bladder cancer	0.000397	0.000743	CcSEcCtD
Cilostazol—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000395	0.000741	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000394	0.000738	CcSEcCtD
Cilostazol—Body temperature increased—Cisplatin—urinary bladder cancer	0.000394	0.000738	CcSEcCtD
Cilostazol—Jaundice—Epirubicin—urinary bladder cancer	0.000391	0.000733	CcSEcCtD
Cilostazol—Pain—Etoposide—urinary bladder cancer	0.00039	0.000731	CcSEcCtD
Cilostazol—Conjunctivitis—Epirubicin—urinary bladder cancer	0.00039	0.00073	CcSEcCtD
Cilostazol—Urinary tract infection—Epirubicin—urinary bladder cancer	0.00039	0.00073	CcSEcCtD
Cilostazol—Haemoglobin—Methotrexate—urinary bladder cancer	0.000387	0.000725	CcSEcCtD
Cilostazol—Haemorrhage—Methotrexate—urinary bladder cancer	0.000385	0.000721	CcSEcCtD
Cilostazol—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000385	0.00072	CcSEcCtD
Cilostazol—Asthenia—Gemcitabine—urinary bladder cancer	0.000384	0.000718	CcSEcCtD
Cilostazol—Haematuria—Epirubicin—urinary bladder cancer	0.000382	0.000717	CcSEcCtD
Cilostazol—Pharyngitis—Methotrexate—urinary bladder cancer	0.000382	0.000715	CcSEcCtD
Cilostazol—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000379	0.000711	CcSEcCtD
Cilostazol—Epistaxis—Epirubicin—urinary bladder cancer	0.000378	0.000709	CcSEcCtD
Cilostazol—Pruritus—Gemcitabine—urinary bladder cancer	0.000378	0.000708	CcSEcCtD
Cilostazol—Nausea—Thiotepa—urinary bladder cancer	0.000377	0.000707	CcSEcCtD
Cilostazol—Sinusitis—Epirubicin—urinary bladder cancer	0.000376	0.000705	CcSEcCtD
Cilostazol—Feeling abnormal—Etoposide—urinary bladder cancer	0.000376	0.000705	CcSEcCtD
Cilostazol—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000374	0.000701	CcSEcCtD
Cilostazol—Pneumonia—Doxorubicin—urinary bladder cancer	0.000373	0.000699	CcSEcCtD
Cilostazol—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000373	0.000699	CcSEcCtD
Cilostazol—Pruritus—Fluorouracil—urinary bladder cancer	0.000372	0.000697	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000368	0.000689	CcSEcCtD
Cilostazol—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000366	0.000685	CcSEcCtD
Cilostazol—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000364	0.000682	CcSEcCtD
Cilostazol—Urticaria—Etoposide—urinary bladder cancer	0.000363	0.000679	CcSEcCtD
Cilostazol—Haemoglobin—Epirubicin—urinary bladder cancer	0.000362	0.000678	CcSEcCtD
Cilostazol—Jaundice—Doxorubicin—urinary bladder cancer	0.000362	0.000678	CcSEcCtD
Cilostazol—Rhinitis—Epirubicin—urinary bladder cancer	0.000361	0.000676	CcSEcCtD
Cilostazol—Body temperature increased—Etoposide—urinary bladder cancer	0.000361	0.000676	CcSEcCtD
Cilostazol—Abdominal pain—Etoposide—urinary bladder cancer	0.000361	0.000676	CcSEcCtD
Cilostazol—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000361	0.000676	CcSEcCtD
Cilostazol—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000361	0.000676	CcSEcCtD
Cilostazol—Haemorrhage—Epirubicin—urinary bladder cancer	0.00036	0.000675	CcSEcCtD
Cilostazol—Diarrhoea—Fluorouracil—urinary bladder cancer	0.00036	0.000674	CcSEcCtD
Cilostazol—Tinnitus—Methotrexate—urinary bladder cancer	0.000359	0.000672	CcSEcCtD
Cilostazol—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000358	0.000671	CcSEcCtD
Cilostazol—Asthenia—Cisplatin—urinary bladder cancer	0.000357	0.00067	CcSEcCtD
Cilostazol—Pharyngitis—Epirubicin—urinary bladder cancer	0.000357	0.00067	CcSEcCtD
Cilostazol—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000357	0.000669	CcSEcCtD
Cilostazol—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000355	0.000665	CcSEcCtD
Cilostazol—Haematuria—Doxorubicin—urinary bladder cancer	0.000354	0.000663	CcSEcCtD
Cilostazol—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000351	0.000658	CcSEcCtD
Cilostazol—Epistaxis—Doxorubicin—urinary bladder cancer	0.00035	0.000656	CcSEcCtD
Cilostazol—Angiopathy—Methotrexate—urinary bladder cancer	0.000349	0.000654	CcSEcCtD
Cilostazol—Sinusitis—Doxorubicin—urinary bladder cancer	0.000348	0.000652	CcSEcCtD
Cilostazol—Dizziness—Fluorouracil—urinary bladder cancer	0.000348	0.000651	CcSEcCtD
Cilostazol—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000347	0.00065	CcSEcCtD
Cilostazol—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000346	0.000649	CcSEcCtD
Cilostazol—Chills—Methotrexate—urinary bladder cancer	0.000345	0.000647	CcSEcCtD
Cilostazol—Diarrhoea—Cisplatin—urinary bladder cancer	0.000341	0.000639	CcSEcCtD
Cilostazol—Erythema multiforme—Epirubicin—urinary bladder cancer	0.00034	0.000638	CcSEcCtD
Cilostazol—Vomiting—Gemcitabine—urinary bladder cancer	0.00034	0.000637	CcSEcCtD
Cilostazol—Rash—Gemcitabine—urinary bladder cancer	0.000337	0.000631	CcSEcCtD
Cilostazol—Dermatitis—Gemcitabine—urinary bladder cancer	0.000337	0.000631	CcSEcCtD
Cilostazol—Tinnitus—Epirubicin—urinary bladder cancer	0.000336	0.000629	CcSEcCtD
Cilostazol—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000335	0.000627	CcSEcCtD
Cilostazol—Headache—Gemcitabine—urinary bladder cancer	0.000335	0.000627	CcSEcCtD
Cilostazol—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000334	0.000626	CcSEcCtD
Cilostazol—Vomiting—Fluorouracil—urinary bladder cancer	0.000334	0.000626	CcSEcCtD
Cilostazol—Rhinitis—Doxorubicin—urinary bladder cancer	0.000334	0.000626	CcSEcCtD
Cilostazol—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000333	0.000624	CcSEcCtD
Cilostazol—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000332	0.000621	CcSEcCtD
Cilostazol—Rash—Fluorouracil—urinary bladder cancer	0.000331	0.000621	CcSEcCtD
Cilostazol—Dermatitis—Fluorouracil—urinary bladder cancer	0.000331	0.00062	CcSEcCtD
Cilostazol—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000331	0.00062	CcSEcCtD
Cilostazol—Headache—Fluorouracil—urinary bladder cancer	0.000329	0.000617	CcSEcCtD
Cilostazol—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000328	0.000615	CcSEcCtD
Cilostazol—Asthenia—Etoposide—urinary bladder cancer	0.000327	0.000613	CcSEcCtD
Cilostazol—Angiopathy—Epirubicin—urinary bladder cancer	0.000327	0.000612	CcSEcCtD
Cilostazol—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000325	0.000608	CcSEcCtD
Cilostazol—Back pain—Methotrexate—urinary bladder cancer	0.000324	0.000607	CcSEcCtD
Cilostazol—Chills—Epirubicin—urinary bladder cancer	0.000323	0.000605	CcSEcCtD
Cilostazol—Pruritus—Etoposide—urinary bladder cancer	0.000323	0.000605	CcSEcCtD
Cilostazol—Nausea—Gemcitabine—urinary bladder cancer	0.000317	0.000595	CcSEcCtD
Cilostazol—Vomiting—Cisplatin—urinary bladder cancer	0.000317	0.000593	CcSEcCtD
Cilostazol—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000315	0.00059	CcSEcCtD
Cilostazol—Rash—Cisplatin—urinary bladder cancer	0.000314	0.000588	CcSEcCtD
Cilostazol—Dermatitis—Cisplatin—urinary bladder cancer	0.000314	0.000588	CcSEcCtD
Cilostazol—Diarrhoea—Etoposide—urinary bladder cancer	0.000312	0.000585	CcSEcCtD
Cilostazol—Nausea—Fluorouracil—urinary bladder cancer	0.000312	0.000585	CcSEcCtD
Cilostazol—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000311	0.000582	CcSEcCtD
Cilostazol—Tinnitus—Doxorubicin—urinary bladder cancer	0.000311	0.000582	CcSEcCtD
Cilostazol—Anaemia—Methotrexate—urinary bladder cancer	0.00031	0.00058	CcSEcCtD
Cilostazol—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.000309	0.000579	CcSEcCtD
Cilostazol—Flatulence—Epirubicin—urinary bladder cancer	0.000309	0.000579	CcSEcCtD
Cilostazol—Back pain—Epirubicin—urinary bladder cancer	0.000303	0.000568	CcSEcCtD
Cilostazol—Angiopathy—Doxorubicin—urinary bladder cancer	0.000302	0.000566	CcSEcCtD
Cilostazol—Malaise—Methotrexate—urinary bladder cancer	0.000302	0.000566	CcSEcCtD
Cilostazol—Dizziness—Etoposide—urinary bladder cancer	0.000302	0.000565	CcSEcCtD
Cilostazol—Muscle spasms—Epirubicin—urinary bladder cancer	0.000301	0.000565	CcSEcCtD
Cilostazol—Vertigo—Methotrexate—urinary bladder cancer	0.000301	0.000564	CcSEcCtD
Cilostazol—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.0003	0.000563	CcSEcCtD
Cilostazol—Leukopenia—Methotrexate—urinary bladder cancer	0.0003	0.000562	CcSEcCtD
Cilostazol—Chills—Doxorubicin—urinary bladder cancer	0.000299	0.00056	CcSEcCtD
Cilostazol—Nausea—Cisplatin—urinary bladder cancer	0.000296	0.000554	CcSEcCtD
Cilostazol—Cough—Methotrexate—urinary bladder cancer	0.000292	0.000548	CcSEcCtD
Cilostazol—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000291	0.000545	CcSEcCtD
Cilostazol—Vomiting—Etoposide—urinary bladder cancer	0.00029	0.000544	CcSEcCtD
Cilostazol—Anaemia—Epirubicin—urinary bladder cancer	0.00029	0.000543	CcSEcCtD
Cilostazol—Rash—Etoposide—urinary bladder cancer	0.000288	0.000539	CcSEcCtD
Cilostazol—Dermatitis—Etoposide—urinary bladder cancer	0.000288	0.000539	CcSEcCtD
Cilostazol—Headache—Etoposide—urinary bladder cancer	0.000286	0.000536	CcSEcCtD
Cilostazol—Flatulence—Doxorubicin—urinary bladder cancer	0.000286	0.000535	CcSEcCtD
Cilostazol—Chest pain—Methotrexate—urinary bladder cancer	0.000285	0.000534	CcSEcCtD
Cilostazol—Myalgia—Methotrexate—urinary bladder cancer	0.000285	0.000534	CcSEcCtD
Cilostazol—Arthralgia—Methotrexate—urinary bladder cancer	0.000285	0.000534	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000283	0.000531	CcSEcCtD
Cilostazol—Malaise—Epirubicin—urinary bladder cancer	0.000283	0.00053	CcSEcCtD
Cilostazol—Discomfort—Methotrexate—urinary bladder cancer	0.000282	0.000528	CcSEcCtD
Cilostazol—Vertigo—Epirubicin—urinary bladder cancer	0.000282	0.000528	CcSEcCtD
Cilostazol—Syncope—Epirubicin—urinary bladder cancer	0.000281	0.000527	CcSEcCtD
Cilostazol—Leukopenia—Epirubicin—urinary bladder cancer	0.000281	0.000526	CcSEcCtD
Cilostazol—Back pain—Doxorubicin—urinary bladder cancer	0.000281	0.000526	CcSEcCtD
Cilostazol—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000279	0.000522	CcSEcCtD
Cilostazol—Palpitations—Epirubicin—urinary bladder cancer	0.000277	0.000519	CcSEcCtD
Cilostazol—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000276	0.000516	CcSEcCtD
Cilostazol—Cough—Epirubicin—urinary bladder cancer	0.000274	0.000512	CcSEcCtD
Cilostazol—Infection—Methotrexate—urinary bladder cancer	0.000272	0.000509	CcSEcCtD
Cilostazol—Nausea—Etoposide—urinary bladder cancer	0.000271	0.000508	CcSEcCtD
Cilostazol—Hypertension—Epirubicin—urinary bladder cancer	0.000271	0.000507	CcSEcCtD
Cilostazol—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000269	0.000504	CcSEcCtD
Cilostazol—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000268	0.000502	CcSEcCtD
Cilostazol—Anaemia—Doxorubicin—urinary bladder cancer	0.000268	0.000502	CcSEcCtD
Cilostazol—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000268	0.000501	CcSEcCtD
Cilostazol—Arthralgia—Epirubicin—urinary bladder cancer	0.000267	0.0005	CcSEcCtD
Cilostazol—Chest pain—Epirubicin—urinary bladder cancer	0.000267	0.0005	CcSEcCtD
Cilostazol—Myalgia—Epirubicin—urinary bladder cancer	0.000267	0.0005	CcSEcCtD
Cilostazol—Anxiety—Epirubicin—urinary bladder cancer	0.000266	0.000498	CcSEcCtD
Cilostazol—Skin disorder—Methotrexate—urinary bladder cancer	0.000266	0.000497	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000265	0.000497	CcSEcCtD
Cilostazol—Discomfort—Epirubicin—urinary bladder cancer	0.000264	0.000494	CcSEcCtD
Cilostazol—Malaise—Doxorubicin—urinary bladder cancer	0.000262	0.00049	CcSEcCtD
Cilostazol—Vertigo—Doxorubicin—urinary bladder cancer	0.000261	0.000488	CcSEcCtD
Cilostazol—Anorexia—Methotrexate—urinary bladder cancer	0.000261	0.000488	CcSEcCtD
Cilostazol—Syncope—Doxorubicin—urinary bladder cancer	0.00026	0.000487	CcSEcCtD
Cilostazol—Leukopenia—Doxorubicin—urinary bladder cancer	0.00026	0.000486	CcSEcCtD
Cilostazol—Palpitations—Doxorubicin—urinary bladder cancer	0.000256	0.00048	CcSEcCtD
Cilostazol—Oedema—Epirubicin—urinary bladder cancer	0.000256	0.000479	CcSEcCtD
Cilostazol—Hypotension—Methotrexate—urinary bladder cancer	0.000255	0.000479	CcSEcCtD
Cilostazol—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000255	0.000478	CcSEcCtD
Cilostazol—Infection—Epirubicin—urinary bladder cancer	0.000254	0.000476	CcSEcCtD
Cilostazol—Cough—Doxorubicin—urinary bladder cancer	0.000253	0.000474	CcSEcCtD
Cilostazol—Shock—Epirubicin—urinary bladder cancer	0.000252	0.000472	CcSEcCtD
Cilostazol—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000251	0.00047	CcSEcCtD
Cilostazol—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000251	0.000469	CcSEcCtD
Cilostazol—Hypertension—Doxorubicin—urinary bladder cancer	0.00025	0.000469	CcSEcCtD
Cilostazol—Tachycardia—Epirubicin—urinary bladder cancer	0.00025	0.000468	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000249	0.000467	CcSEcCtD
Cilostazol—Skin disorder—Epirubicin—urinary bladder cancer	0.000249	0.000466	CcSEcCtD
Cilostazol—Insomnia—Methotrexate—urinary bladder cancer	0.000247	0.000463	CcSEcCtD
Cilostazol—Chest pain—Doxorubicin—urinary bladder cancer	0.000247	0.000463	CcSEcCtD
Cilostazol—Myalgia—Doxorubicin—urinary bladder cancer	0.000247	0.000463	CcSEcCtD
Cilostazol—Arthralgia—Doxorubicin—urinary bladder cancer	0.000247	0.000463	CcSEcCtD
Cilostazol—Anxiety—Doxorubicin—urinary bladder cancer	0.000246	0.000461	CcSEcCtD
Cilostazol—Paraesthesia—Methotrexate—urinary bladder cancer	0.000245	0.00046	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000245	0.000459	CcSEcCtD
Cilostazol—Discomfort—Doxorubicin—urinary bladder cancer	0.000244	0.000457	CcSEcCtD
Cilostazol—Anorexia—Epirubicin—urinary bladder cancer	0.000244	0.000457	CcSEcCtD
Cilostazol—Dyspnoea—Methotrexate—urinary bladder cancer	0.000244	0.000457	CcSEcCtD
Cilostazol—Dyspepsia—Methotrexate—urinary bladder cancer	0.000241	0.000451	CcSEcCtD
Cilostazol—Hypotension—Epirubicin—urinary bladder cancer	0.000239	0.000448	CcSEcCtD
Cilostazol—Decreased appetite—Methotrexate—urinary bladder cancer	0.000238	0.000445	CcSEcCtD
Cilostazol—Oedema—Doxorubicin—urinary bladder cancer	0.000237	0.000443	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000236	0.000442	CcSEcCtD
Cilostazol—Infection—Doxorubicin—urinary bladder cancer	0.000235	0.000441	CcSEcCtD
Cilostazol—Pain—Methotrexate—urinary bladder cancer	0.000234	0.000438	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000233	0.000437	CcSEcCtD
Cilostazol—Shock—Doxorubicin—urinary bladder cancer	0.000233	0.000436	CcSEcCtD
Cilostazol—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000232	0.000435	CcSEcCtD
Cilostazol—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000232	0.000434	CcSEcCtD
Cilostazol—Insomnia—Epirubicin—urinary bladder cancer	0.000231	0.000434	CcSEcCtD
Cilostazol—Tachycardia—Doxorubicin—urinary bladder cancer	0.000231	0.000433	CcSEcCtD
Cilostazol—Skin disorder—Doxorubicin—urinary bladder cancer	0.00023	0.000431	CcSEcCtD
Cilostazol—Paraesthesia—Epirubicin—urinary bladder cancer	0.00023	0.00043	CcSEcCtD
Cilostazol—Dyspnoea—Epirubicin—urinary bladder cancer	0.000228	0.000427	CcSEcCtD
Cilostazol—Anorexia—Doxorubicin—urinary bladder cancer	0.000226	0.000423	CcSEcCtD
Cilostazol—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000225	0.000422	CcSEcCtD
Cilostazol—Dyspepsia—Epirubicin—urinary bladder cancer	0.000225	0.000422	CcSEcCtD
Cilostazol—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000224	0.000419	CcSEcCtD
Cilostazol—Decreased appetite—Epirubicin—urinary bladder cancer	0.000222	0.000417	CcSEcCtD
Cilostazol—Hypotension—Doxorubicin—urinary bladder cancer	0.000221	0.000414	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000221	0.000414	CcSEcCtD
Cilostazol—Pain—Epirubicin—urinary bladder cancer	0.000219	0.00041	CcSEcCtD
Cilostazol—Urticaria—Methotrexate—urinary bladder cancer	0.000217	0.000407	CcSEcCtD
Cilostazol—Abdominal pain—Methotrexate—urinary bladder cancer	0.000216	0.000405	CcSEcCtD
Cilostazol—Body temperature increased—Methotrexate—urinary bladder cancer	0.000216	0.000405	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000216	0.000404	CcSEcCtD
Cilostazol—Insomnia—Doxorubicin—urinary bladder cancer	0.000214	0.000401	CcSEcCtD
Cilostazol—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000213	0.000398	CcSEcCtD
Cilostazol—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000211	0.000395	CcSEcCtD
Cilostazol—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000211	0.000395	CcSEcCtD
Cilostazol—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000209	0.000392	CcSEcCtD
Cilostazol—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000208	0.00039	CcSEcCtD
Cilostazol—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000206	0.000386	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000204	0.000383	CcSEcCtD
Cilostazol—Urticaria—Epirubicin—urinary bladder cancer	0.000203	0.000381	CcSEcCtD
Cilostazol—Pain—Doxorubicin—urinary bladder cancer	0.000202	0.000379	CcSEcCtD
Cilostazol—Abdominal pain—Epirubicin—urinary bladder cancer	0.000202	0.000379	CcSEcCtD
Cilostazol—Body temperature increased—Epirubicin—urinary bladder cancer	0.000202	0.000379	CcSEcCtD
Cilostazol—Asthenia—Methotrexate—urinary bladder cancer	0.000196	0.000367	CcSEcCtD
Cilostazol—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000195	0.000365	CcSEcCtD
Cilostazol—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000194	0.000363	CcSEcCtD
Cilostazol—Pruritus—Methotrexate—urinary bladder cancer	0.000193	0.000362	CcSEcCtD
Cilostazol—Urticaria—Doxorubicin—urinary bladder cancer	0.000188	0.000352	CcSEcCtD
Cilostazol—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000187	0.000351	CcSEcCtD
Cilostazol—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000187	0.000351	CcSEcCtD
Cilostazol—Diarrhoea—Methotrexate—urinary bladder cancer	0.000187	0.00035	CcSEcCtD
Cilostazol—Asthenia—Epirubicin—urinary bladder cancer	0.000184	0.000344	CcSEcCtD
Cilostazol—Pruritus—Epirubicin—urinary bladder cancer	0.000181	0.000339	CcSEcCtD
Cilostazol—Dizziness—Methotrexate—urinary bladder cancer	0.000181	0.000339	CcSEcCtD
Cilostazol—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000181	0.00123	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTZ1—urinary bladder cancer	0.000179	0.00122	CbGpPWpGaD
Cilostazol—CYP1A2—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000177	0.00121	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—urinary bladder cancer	0.000176	0.0012	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000176	0.0012	CbGpPWpGaD
Cilostazol—Diarrhoea—Epirubicin—urinary bladder cancer	0.000175	0.000328	CcSEcCtD
Cilostazol—Vomiting—Methotrexate—urinary bladder cancer	0.000174	0.000326	CcSEcCtD
Cilostazol—Rash—Methotrexate—urinary bladder cancer	0.000172	0.000323	CcSEcCtD
Cilostazol—Dermatitis—Methotrexate—urinary bladder cancer	0.000172	0.000323	CcSEcCtD
Cilostazol—Headache—Methotrexate—urinary bladder cancer	0.000171	0.000321	CcSEcCtD
Cilostazol—CYP3A7—Metabolism—GSTO2—urinary bladder cancer	0.00017	0.00116	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—NAT1—urinary bladder cancer	0.00017	0.00116	CbGpPWpGaD
Cilostazol—Asthenia—Doxorubicin—urinary bladder cancer	0.00017	0.000318	CcSEcCtD
Cilostazol—Dizziness—Epirubicin—urinary bladder cancer	0.000169	0.000317	CcSEcCtD
Cilostazol—Pruritus—Doxorubicin—urinary bladder cancer	0.000167	0.000314	CcSEcCtD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000166	0.00113	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—CREBBP—urinary bladder cancer	0.000165	0.00112	CbGpPWpGaD
Cilostazol—CYP2C19—Biological oxidations—GSTP1—urinary bladder cancer	0.000164	0.00111	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—IGF1—urinary bladder cancer	0.000163	0.00111	CbGpPWpGaD
Cilostazol—Vomiting—Epirubicin—urinary bladder cancer	0.000163	0.000305	CcSEcCtD
Cilostazol—Nausea—Methotrexate—urinary bladder cancer	0.000162	0.000304	CcSEcCtD
Cilostazol—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000162	0.000303	CcSEcCtD
Cilostazol—CYP2C19—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000161	0.0011	CbGpPWpGaD
Cilostazol—Rash—Epirubicin—urinary bladder cancer	0.000161	0.000302	CcSEcCtD
Cilostazol—Dermatitis—Epirubicin—urinary bladder cancer	0.000161	0.000302	CcSEcCtD
Cilostazol—Headache—Epirubicin—urinary bladder cancer	0.00016	0.0003	CcSEcCtD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000158	0.00107	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—urinary bladder cancer	0.000158	0.00107	CbGpPWpGaD
Cilostazol—Dizziness—Doxorubicin—urinary bladder cancer	0.000157	0.000293	CcSEcCtD
Cilostazol—CYP3A7—Metabolism—UGT2B7—urinary bladder cancer	0.000155	0.00106	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000153	0.00104	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—urinary bladder cancer	0.000153	0.00104	CbGpPWpGaD
Cilostazol—Nausea—Epirubicin—urinary bladder cancer	0.000152	0.000285	CcSEcCtD
Cilostazol—Vomiting—Doxorubicin—urinary bladder cancer	0.000151	0.000282	CcSEcCtD
Cilostazol—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	0.00015	0.00102	CbGpPWpGaD
Cilostazol—CYP2C19—Biological oxidations—GSTM1—urinary bladder cancer	0.00015	0.00102	CbGpPWpGaD
Cilostazol—Rash—Doxorubicin—urinary bladder cancer	0.000149	0.00028	CcSEcCtD
Cilostazol—PDE3A—Hemostasis—RHOA—urinary bladder cancer	0.000149	0.00102	CbGpPWpGaD
Cilostazol—Dermatitis—Doxorubicin—urinary bladder cancer	0.000149	0.000279	CcSEcCtD
Cilostazol—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000148	0.00101	CbGpPWpGaD
Cilostazol—Headache—Doxorubicin—urinary bladder cancer	0.000148	0.000278	CcSEcCtD
Cilostazol—CYP2C19—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000148	0.00101	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	0.000146	0.000996	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	0.000142	0.000966	CbGpPWpGaD
Cilostazol—Nausea—Doxorubicin—urinary bladder cancer	0.000141	0.000263	CcSEcCtD
Cilostazol—CYP3A7—Metabolism—CYP4B1—urinary bladder cancer	0.00014	0.000953	CbGpPWpGaD
Cilostazol—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	0.000138	0.000941	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000137	0.000935	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000137	0.000931	CbGpPWpGaD
Cilostazol—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000136	0.000928	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000134	0.000915	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—urinary bladder cancer	0.000134	0.000915	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—SLC19A1—urinary bladder cancer	0.000132	0.0009	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTZ1—urinary bladder cancer	0.00013	0.000882	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PRSS3—urinary bladder cancer	0.000129	0.000877	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000128	0.000871	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000128	0.000871	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	0.000127	0.000867	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000127	0.000864	CbGpPWpGaD
Cilostazol—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000126	0.000855	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—IL2—urinary bladder cancer	0.000125	0.000852	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—RBX1—urinary bladder cancer	0.000125	0.000848	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTO2—urinary bladder cancer	0.000123	0.000836	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NAT1—urinary bladder cancer	0.000123	0.000836	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TSC1—urinary bladder cancer	0.000117	0.000797	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	0.000117	0.000797	CbGpPWpGaD
Cilostazol—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	0.000116	0.000786	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—UGT2B7—urinary bladder cancer	0.000112	0.000765	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—EP300—urinary bladder cancer	0.000112	0.000764	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—JAG1—urinary bladder cancer	0.000112	0.000759	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—SRC—urinary bladder cancer	0.000109	0.000743	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000108	0.000735	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—TYMP—urinary bladder cancer	0.000103	0.000701	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP4B1—urinary bladder cancer	0.000101	0.000689	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	0.0001	0.000682	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	9.84e-05	0.000669	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	9.7e-05	0.00066	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	9.56e-05	0.00065	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	9.5e-05	0.000646	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NAT1—urinary bladder cancer	9.5e-05	0.000646	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—RHOA—urinary bladder cancer	9.43e-05	0.000642	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	9.35e-05	0.000636	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—NAT2—urinary bladder cancer	9.32e-05	0.000634	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	9.31e-05	0.000634	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	9.22e-05	0.000627	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—KRAS—urinary bladder cancer	9.04e-05	0.000615	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	9.04e-05	0.000615	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—S100B—urinary bladder cancer	9.03e-05	0.000615	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.92e-05	0.000607	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	8.74e-05	0.000595	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NAT1—urinary bladder cancer	8.74e-05	0.000595	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	8.69e-05	0.000591	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—RHOA—urinary bladder cancer	8.56e-05	0.000583	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—CXCL8—urinary bladder cancer	8.28e-05	0.000563	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NCOR1—urinary bladder cancer	8.12e-05	0.000553	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—RRM2—urinary bladder cancer	8.04e-05	0.000547	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—TP53—urinary bladder cancer	8.04e-05	0.000547	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	7.99e-05	0.000544	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—IL2—urinary bladder cancer	7.91e-05	0.000538	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	7.82e-05	0.000532	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	7.81e-05	0.000531	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—HRAS—urinary bladder cancer	7.69e-05	0.000523	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—CXCL8—urinary bladder cancer	7.52e-05	0.000511	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ENO2—urinary bladder cancer	7.45e-05	0.000507	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	7.45e-05	0.000507	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—TYMP—urinary bladder cancer	7.45e-05	0.000507	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	7.4e-05	0.000504	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NAT1—urinary bladder cancer	7.4e-05	0.000504	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	7.39e-05	0.000503	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7.28e-05	0.000495	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	7.22e-05	0.000491	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	7.2e-05	0.00049	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	7.2e-05	0.00049	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—IL2—urinary bladder cancer	7.18e-05	0.000489	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TERT—urinary bladder cancer	7.16e-05	0.000487	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	6.8e-05	0.000462	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	6.77e-05	0.000461	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NAT2—urinary bladder cancer	6.73e-05	0.000458	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	6.62e-05	0.000451	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—FGFR3—urinary bladder cancer	6.57e-05	0.000447	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—ESR1—urinary bladder cancer	6.38e-05	0.000434	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	6.1e-05	0.000415	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	6.03e-05	0.00041	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—NQO1—urinary bladder cancer	6e-05	0.000408	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—RRM2—urinary bladder cancer	5.81e-05	0.000396	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.77e-05	0.000393	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	5.76e-05	0.000392	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—TYMP—urinary bladder cancer	5.76e-05	0.000392	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	5.71e-05	0.000389	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NAT1—urinary bladder cancer	5.71e-05	0.000389	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	5.61e-05	0.000382	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CREBBP—urinary bladder cancer	5.59e-05	0.00038	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.53e-05	0.000376	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IGF1—urinary bladder cancer	5.52e-05	0.000376	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—EGFR—urinary bladder cancer	5.49e-05	0.000374	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	5.38e-05	0.000366	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ENO2—urinary bladder cancer	5.38e-05	0.000366	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—TYMP—urinary bladder cancer	5.29e-05	0.00036	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	5.23e-05	0.000356	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	5.22e-05	0.000355	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NAT2—urinary bladder cancer	5.21e-05	0.000354	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—KRAS—urinary bladder cancer	5.19e-05	0.000353	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—RHOA—urinary bladder cancer	5.06e-05	0.000344	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	5.01e-05	0.000341	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NAT2—urinary bladder cancer	4.79e-05	0.000326	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	4.71e-05	0.00032	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—ERBB2—urinary bladder cancer	4.68e-05	0.000319	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—TYMS—urinary bladder cancer	4.65e-05	0.000317	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	4.6e-05	0.000313	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	4.6e-05	0.000313	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.5e-05	0.000306	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—RRM2—urinary bladder cancer	4.49e-05	0.000306	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—TYMP—urinary bladder cancer	4.49e-05	0.000305	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.44e-05	0.000302	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CXCL8—urinary bladder cancer	4.44e-05	0.000302	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—HRAS—urinary bladder cancer	4.41e-05	0.0003	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GPX1—urinary bladder cancer	4.41e-05	0.0003	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NQO1—urinary bladder cancer	4.34e-05	0.000295	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.33e-05	0.000295	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	4.33e-05	0.000294	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.31e-05	0.000293	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL2—urinary bladder cancer	4.24e-05	0.000289	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ENO2—urinary bladder cancer	4.16e-05	0.000283	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	4.16e-05	0.000283	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.14e-05	0.000282	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CCND1—urinary bladder cancer	4.14e-05	0.000281	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—RRM2—urinary bladder cancer	4.13e-05	0.000281	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	4.07e-05	0.000277	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NAT2—urinary bladder cancer	4.06e-05	0.000276	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	4.04e-05	0.000275	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MMP9—urinary bladder cancer	4.02e-05	0.000273	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CDKN1A—urinary bladder cancer	4e-05	0.000272	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PTEN—urinary bladder cancer	3.99e-05	0.000272	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.97e-05	0.00027	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	3.83e-05	0.00026	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ENO2—urinary bladder cancer	3.83e-05	0.00026	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—EP300—urinary bladder cancer	3.81e-05	0.000259	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	3.71e-05	0.000253	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—SRC—urinary bladder cancer	3.7e-05	0.000252	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	3.62e-05	0.000246	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—RRM2—urinary bladder cancer	3.5e-05	0.000238	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.46e-05	0.000236	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—TYMS—urinary bladder cancer	3.36e-05	0.000229	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NQO1—urinary bladder cancer	3.35e-05	0.000228	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	3.33e-05	0.000226	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	3.33e-05	0.000226	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MYC—urinary bladder cancer	3.32e-05	0.000226	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PPARG—urinary bladder cancer	3.3e-05	0.000224	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.25e-05	0.000221	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—EGFR—urinary bladder cancer	3.25e-05	0.000221	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	3.24e-05	0.000221	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ENO2—urinary bladder cancer	3.24e-05	0.000221	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.22e-05	0.000219	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GPX1—urinary bladder cancer	3.18e-05	0.000217	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	3.17e-05	0.000216	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	3.15e-05	0.000214	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.13e-05	0.000213	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	3.13e-05	0.000213	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.1e-05	0.000211	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NQO1—urinary bladder cancer	3.09e-05	0.00021	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—KRAS—urinary bladder cancer	3.07e-05	0.000209	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	2.94e-05	0.0002	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.84e-05	0.000193	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	2.8e-05	0.00019	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TP53—urinary bladder cancer	2.73e-05	0.000185	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.71e-05	0.000184	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.7e-05	0.000184	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NQO1—urinary bladder cancer	2.61e-05	0.000178	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—HRAS—urinary bladder cancer	2.61e-05	0.000177	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—TYMS—urinary bladder cancer	2.6e-05	0.000177	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	2.59e-05	0.000176	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	2.57e-05	0.000175	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	2.57e-05	0.000175	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	2.57e-05	0.000175	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.54e-05	0.000173	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.5e-05	0.00017	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.5e-05	0.00017	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GPX1—urinary bladder cancer	2.46e-05	0.000168	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.43e-05	0.000165	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	2.42e-05	0.000164	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—TYMS—urinary bladder cancer	2.39e-05	0.000163	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PPARG—urinary bladder cancer	2.38e-05	0.000162	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	2.36e-05	0.000161	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	2.36e-05	0.000161	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	2.29e-05	0.000156	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	2.27e-05	0.000155	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.26e-05	0.000154	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTEN—urinary bladder cancer	2.26e-05	0.000154	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	2.22e-05	0.000151	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.21e-05	0.00015	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	2.18e-05	0.000148	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—EP300—urinary bladder cancer	2.16e-05	0.000147	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.11e-05	0.000144	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.09e-05	0.000142	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—TYMS—urinary bladder cancer	2.03e-05	0.000138	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.02e-05	0.000137	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	2e-05	0.000136	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	2e-05	0.000136	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.92e-05	0.000131	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.88e-05	0.000128	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.87e-05	0.000128	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.84e-05	0.000125	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.77e-05	0.00012	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.77e-05	0.00012	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.69e-05	0.000115	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.68e-05	0.000114	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTEN—urinary bladder cancer	1.64e-05	0.000111	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.63e-05	0.000111	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.56e-05	0.000106	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—EP300—urinary bladder cancer	1.56e-05	0.000106	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.55e-05	0.000105	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.55e-05	0.000105	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.48e-05	0.000101	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.45e-05	9.89e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.45e-05	9.86e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.44e-05	9.77e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.38e-05	9.38e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.37e-05	9.3e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.33e-05	9.07e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.26e-05	8.6e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.21e-05	8.2e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.16e-05	7.91e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1.13e-05	7.68e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.11e-05	7.54e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.11e-05	7.54e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.06e-05	7.24e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTEN—urinary bladder cancer	9.85e-06	6.7e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—EP300—urinary bladder cancer	9.39e-06	6.39e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	8.72e-06	5.93e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTEN—urinary bladder cancer	7.6e-06	5.17e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—EP300—urinary bladder cancer	7.25e-06	4.93e-05	CbGpPWpGaD
